Track Option Care Health, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Option Care Health, Inc. OPCH · Stock Open Option Care Health, Inc. in new tab

31.65 USD
P/E
22.95
EPS
1.38
P/B
3.58
ROE
16.04
Beta
0.46
Target Price
30.03 USD
Option Care Health, Inc. logo

Option Care Health, Inc.

🧾 Earnings Recap – Q1 2026

Option Care Health shares fell 25.5% after first quarter results, as investors reacted to a revenue growth deceleration and a downward revision to full-year revenue guidance stemming from an unexpected drop in the chronic therapy patient census and delayed program launches.

  • Reported revenue growth of just 1% for Q1, below company expectations, with chronic therapy revenues declining year-over-year.
  • Acute therapy portfolio delivered high single-digit revenue growth, outperforming market growth rates.
  • Chronic portfolio faced headwinds including a "significantly higher" number of patients affected by insurance changes, causing patient census to fall more than anticipated and leading to a less favorable therapy mix.
  • Guidance for full-year revenue was revised down due to more challenging industry dynamics, regulatory or commercial delays in rare/orphan portfolio launches, and slower-than-expected growth in specialty therapies.
  • Management is reallocating resources, increasing commercial team size, and refocusing growth initiatives in response to these challenges.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 23, 2027
P/E22.95
EPS1.38
Book Value8.84
Price to Book3.58
Debt/Equity95.32
% Insiders1.101%
Growth
Revenue Growth0.04%
Earnings Growth0.19%
Estimates
Forward P/E15.19
Forward EPS2.08
Target Mean Price30.03

DCF valuation

Model fair value for Option Care Health, Inc. (OPCH)
Result
Sign in to run the valuation for OPCH.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
8 analysts · consensus Hold · mean target 30.03 USD (low 23.00, high 33.00) · as of 12 Nov 2026
Low 23.00
Mean 30.03
High 33.00
Price 31.65
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Option Care Health, Inc. Logo Option Care Health, Inc. Analysis (OPCH)

United States Health Care Official Website Stock

Is Option Care Health, Inc. a good investment? Option Care Health, Inc. (OPCH) is currently trading at 31.65 USD. Market analysts have a consensus price target of 30.03 USD. This suggests the asset is currently trading above analyst expectations.

In terms of valuation, the stock trades at a P/E ratio of 22.95. This valuation is generally in line with the broader market.

Earnings Schedule: Option Care Health, Inc. is expected to release its next earnings report on Feb. 23, 2027. The market consensus estimate for Forward EPS is 2.08.

Investor FAQ

Does Option Care Health, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Option Care Health, Inc.?

Option Care Health, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 23, 2027. The company currently has a trailing EPS of 1.38.

Company Profile

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.

Exchange Ticker
FRA (Germany) MM6A.F
NMS (United States) OPCH
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Feb. 3, 2020 1:4
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion